Elevation Oncology Inc. (ELEV)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2024, 4:32 pm based on SEC 13F filings Last update: November 14, 2024, 4:32 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Tang Capital Management Kevin C. Tang	4,760,000	$2,855,524	+56%	0.2%
2.	Farallon Capital Thomas Steyer	3,527,482	$2,116,136	-2%	0.01%
3.	Biotechnology Value Fund / BVF Inc Mark Lampert	2,966,836	$1,779,805	+29%	0.05%
4.	Renaissance Technologies Jim Simons	1,785,982	$1,071,411		0%
5.	Hudson Bay Capital Management Sander Gerber	1,359,246	$815,412	-44%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Qiming	$16.00	312,500	Large Shareholder	2,370,142	2021-06-29	Filing
Aisling	$16.00	187,500	Large Shareholder	2,834,910	2021-06-29	Filing
Vertex	$16.00	250,000	Large Shareholder	2,307,642	2021-06-29	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Venbio	$4.12	702,737		1,905,430	2022-05-25	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Venbio Partners Llc	2,914,255	$1,564,955	0.23%
2.	Aisling Capital Management Lp	2,834,910	$1,522,347	0.45%
3.	Qiming U.s. Ventures Management, Llc	2,370,142	$1,272,766	1.16%
4.	Vanguard Group Inc	1,171,246	$628,959	0%
5.	Two Sigma Investments, Lp	364,892	$195,947	0%